ArticleRheumatology international2025

Janus kinase inhibitors show a longer drug survival than biologics in a real-world cohort of patients with rheumatoid arthritis - a retrospective analysis from the RHADAR database.

Linus Maximilian Risser et al.PubMed ↗Publisher ↗

No numbers read from the abstract.